drugset / Trial / NCT06846138

Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study

NCT06846138 ↗

Enrolling by invitation 66 enrolled Pauls Stradins Clinical University Hospital
RandomizedCrossoverSingle-blindTreatment

Summary

Study population: Type 2 diabetes patients Design of the study: Randomized, two-arm, placebo-controlled, and prospective crossover cohort study. Objective: To evaluate the effects of interactions between metformin and traditionally used polyherbal formulations on gut microbiota in a prospective crossover study involving type 2 diabetes mellitus patients. Sample size: 66 patients. Duration of study: 06/2024 - 12/2026

Timeline

Start
2025-03-01
Primary completion
2026-12-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — Oral
Subject Polyherbal Formulation (PHF) Unknown — Oral